| Style | Citing Format |
|---|---|
| MLA | Bikdeli B, et al.. "Intermediate-Dose Versus Standard-Dose Prophylactic Anticoagulation in Patients With Covid-19 Admitted to the Intensive Care Unit: 90-Day Results From the Inspiration Randomized Trial." Thrombosis and Haemostasis, vol. 122, no. 1, 2021, pp. 131-141. |
| APA | Bikdeli B, Talasaz AH, Rashidi F, Bakhshandeh H, Rafiee F, Rezaeifar P, Baghizadeh E, Matin S, Jamalkhani S, Tahamtan O, Sharifkashani B, Beigmohammadi MT, Farrokhpour M, Sezavar SH, Payandemehr P, Dabbagh A, Moghadam KG, Khalili H, Yadollahzadeh M, ... Sadeghipour P (2021). Intermediate-Dose Versus Standard-Dose Prophylactic Anticoagulation in Patients With Covid-19 Admitted to the Intensive Care Unit: 90-Day Results From the Inspiration Randomized Trial. Thrombosis and Haemostasis, 122(1), 131-141. |
| Chicago | Bikdeli B, Talasaz AH, Rashidi F, Bakhshandeh H, Rafiee F, Rezaeifar P, Baghizadeh E, et al.. "Intermediate-Dose Versus Standard-Dose Prophylactic Anticoagulation in Patients With Covid-19 Admitted to the Intensive Care Unit: 90-Day Results From the Inspiration Randomized Trial." Thrombosis and Haemostasis 122, no. 1 (2021): 131-141. |
| Harvard | Bikdeli B et al. (2021) 'Intermediate-Dose Versus Standard-Dose Prophylactic Anticoagulation in Patients With Covid-19 Admitted to the Intensive Care Unit: 90-Day Results From the Inspiration Randomized Trial', Thrombosis and Haemostasis, 122(1), pp. 131-141. |
| Vancouver | Bikdeli B, Talasaz AH, Rashidi F, Bakhshandeh H, Rafiee F, Rezaeifar P, et al.. Intermediate-Dose Versus Standard-Dose Prophylactic Anticoagulation in Patients With Covid-19 Admitted to the Intensive Care Unit: 90-Day Results From the Inspiration Randomized Trial. Thrombosis and Haemostasis. 2021;122(1):131-141. |
| BibTex | @article{ author = {Bikdeli B and Talasaz AH and Rashidi F and Bakhshandeh H and Rafiee F and Rezaeifar P and Baghizadeh E and Matin S and Jamalkhani S and Tahamtan O and Sharifkashani B and Beigmohammadi MT and Farrokhpour M and Sezavar SH and Payandemehr P and Dabbagh A and Moghadam KG and Khalili H and Yadollahzadeh M and Riahi T and Abedini A and Lookzadeh S and Rahmani H and Zoghi E and Mohammadi K and Sadeghipour P and Abri H and Tabrizi S and Mousavian SM and Shahmirzaei S and Amin A and Mohebbi B and Parhizgar SE and Aliannejad R and Eslami V and Kashefizadeh A and Dobesh PP and Kakavand H and Hosseini SH and Shafaghi S and Ghazi SF and Najafi A and Jimenez D and Gupta A and Madhavan MV and Sethi SS and Parikh SA and Monreal M and Hadavand N and Hajighasemi A and Maleki M and Sadeghian S and Piazza G and Kirtane AJ and Van Tassell BW and Stone GW and Lip GYH and Krumholz HM and Goldhaber SZ and Sadeghipour P}, title = {Intermediate-Dose Versus Standard-Dose Prophylactic Anticoagulation in Patients With Covid-19 Admitted to the Intensive Care Unit: 90-Day Results From the Inspiration Randomized Trial}, journal = {Thrombosis and Haemostasis}, volume = {122}, number = {1}, pages = {131-141}, year = {2021} } |
| RIS | TY - JOUR AU - Bikdeli B AU - Talasaz AH AU - Rashidi F AU - Bakhshandeh H AU - Rafiee F AU - Rezaeifar P AU - Baghizadeh E AU - Matin S AU - Jamalkhani S AU - Tahamtan O AU - Sharifkashani B AU - Beigmohammadi MT AU - Farrokhpour M AU - Sezavar SH AU - Payandemehr P AU - Dabbagh A AU - Moghadam KG AU - Khalili H AU - Yadollahzadeh M AU - Riahi T AU - Abedini A AU - Lookzadeh S AU - Rahmani H AU - Zoghi E AU - Mohammadi K AU - Sadeghipour P AU - Abri H AU - Tabrizi S AU - Mousavian SM AU - Shahmirzaei S AU - Amin A AU - Mohebbi B AU - Parhizgar SE AU - Aliannejad R AU - Eslami V AU - Kashefizadeh A AU - Dobesh PP AU - Kakavand H AU - Hosseini SH AU - Shafaghi S AU - Ghazi SF AU - Najafi A AU - Jimenez D AU - Gupta A AU - Madhavan MV AU - Sethi SS AU - Parikh SA AU - Monreal M AU - Hadavand N AU - Hajighasemi A AU - Maleki M AU - Sadeghian S AU - Piazza G AU - Kirtane AJ AU - Van Tassell BW AU - Stone GW AU - Lip GYH AU - Krumholz HM AU - Goldhaber SZ AU - Sadeghipour P TI - Intermediate-Dose Versus Standard-Dose Prophylactic Anticoagulation in Patients With Covid-19 Admitted to the Intensive Care Unit: 90-Day Results From the Inspiration Randomized Trial JO - Thrombosis and Haemostasis VL - 122 IS - 1 SP - 131 EP - 141 PY - 2021 ER - |